Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.
|Published (Last):||4 August 2008|
|PDF File Size:||8.41 Mb|
|ePub File Size:||18.26 Mb|
|Price:||Free* [*Free Regsitration Required]|
Are you a health professional able to prescribe or dispense drugs? Continuing navigation will be considered as acceptance of this use.
Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos
This item has received. Subscribe to our Newsletter. SRJ is a prestige metric based on the idea that not all citations are the same.
The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns. Subscriber If you already have your login data, please click here.
They received between 1 to 5 cycles with rTPA. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.
Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator. CiteScore measures average citations received per document published. Nine issues are published each year, including mostly originals, reviews and consensus documents. You can change the settings or obtain more information by clicking here.
There were no deaths or embolism.
There was a problem providing the content you requested
The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them.
From Monday to Friday from 9 a. The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.
To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. Print Send to a friend Export reference Mendeley Statistics.
The patients included 4 males with a mean weight of gr. Three patients received low molecular weight heparin prior to using rTPA.
March Pages ee24 Pages Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an dwl to heparin in life threatening giant thrombus and embolization. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns. Previous article Next article. The superior vena cava was the most frequent location, with a mean time of installation yisular the diagnosis of 12 days.
In 4 patients complete resolution of the thrombus was achieved in a mean of 3. Si continua navegando, consideramos que acepta su uso.
The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Four patients had intracranial haemorrhage grade I, without sequelae at follow-up.